Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
Biden Administration Provides Update on Opioid Crisis Funding
In late September 2022, United States President Joe Biden released a statement regarding what his administration has done to help…
Teva Announces $4.25 Billion Proposed Settlement
In late July 2022, Teva Pharmaceutical Industries announced a $4.25 billion proposed nationwide settlement to resolve thousands of…
Allergan Reaches $2 Billion Settlement Over Improper Marketing of Opioids
AbbVie’s Allergan unit has allegedly reached an agreement to pay more than $2 billion to resolve lawsuits filed by state and local…
Court Rules in Favor of Three Major Opioid Distributors in West Virginia…
On Monday, July 4, 2022, United States District Court Judge David Faber ruled in favor of three opioid distributors – Amerisource…
Alabama Reaches $276 Million in Opioid-Related Settlements
In mid-April 2022, Alabama announced that it reached $276 million in settlements with Johnson & Johnson, McKesson Corp., and…
Policy and Medicine Compliance Update — Sun Pharma Anti Trust…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
CVS Reaches $484 Million Opioid Settlement with Florida
At the end of March 2022, CVS Health announced a $484 million settlement with the State of Florida to resolve long-standing claims…
Study Finds that Laws Meant to Curb Opioid Prescribing Practices Are Not…
On March 15, 2022, a study led by researchers at Johns Hopkins Bloomberg School of Public Health was published in the Annals of…
FDA Requests Comments on Potential Modification to Opioid Analgesic Risk…
On April 21, 2022, the United States Food and Drug Administration (FDA) filed a Notice and Request for Comment regarding a…
Teva Reaches $225 Million Settlement with Texas Over Opioid Claims
On Monday, February 14, 2022, Texas Attorney General Ken Paxton announced a $225 million settlement with Teva Pharmaceutical…